Trial Profile
Impact of Hepatitis C virus eradication on the outcomeS of patients with HCV related advanced hepatocellular carcinoma treated with sorafenib: a retrospective, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Sep 2017 New trial record